After careful review and discussion, the DCAT Board of Directors determined that an amendment to the organization’s current bylaws was required during its recent meeting in New York City. Use the link below to view this amendment.
On or about July 30, 2018, membership renewal instructions will be emailed to designated contacts at DCAT member companies. Membership fees are due prior to the start of DCAT’s fiscal year on November 1, 2018.
July 11, 2018
Mid-Year Review: New Drug Approvals Stay on Track
DCAT Value Chain Insights takes an inside look on the FDA's new drug approvals. Read More
The DCAT organization is proud to announce the winners of four scholarships presented at the Intel International Science & Engineering Fair (Intel ISEF) held on May 17th in Pittsburgh, PA.
Now accepting applications for representatives of member companies who are passionate about the DCAT association community and want to serve on its Board of Directors.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.